The application of nanocarriers as selective drug delivery platforms, as imaging or as
diagnostic agents has been evaluated in several studies in the area of biomedicine, namely …

In the last few years mesoporous silica nanoparticles (MSNs) have gained the attention of
the nanomedicine research community, especially for the potential treatment of cancer …

Nanoparticles have become a powerful tool in oncology not only as carrier of the highly toxic
chemotherapeutic drugs but also as imaging contrast agents that provide valuable …

The implementation of nanotechnology in medicine has opened new research horizons
particularly in the field of therapeutic delivery. Mesoporous silica particles have emerged as …

ABSTRACT Introduction Mesoporous silica nanoparticles (MSNs) are outstanding
nanoplatforms for drug delivery. Herein, the most recent advances to turn MSN-based …

The application of nanomaterials is regarded nowadays as a highly promising approach for
overcoming the limitations of the currently available cancer treatments, contributing for the …

Mesoporous silica nanoparticles have been widely applied as carriers for cancer treatment.
Among the different types of stimuli-responsive drug delivery systems, those sensitive to …

Nanoparticles that respond to internal and external stimuli to carry out controlled release of
anticancer drugs have been developed. In this review, we focus on the development of …

Introduction: Mesoporous silica nanoparticles (MSNPs) are one of the most promising
inorganic drug delivery systems (DDSs). The design and development of tumour-targeted …

Targeted delivery of anticancer drug specifically to tumor site without damaging normal
tissues has been the dream of all scientists fighting against cancer for decades. Recent …